Matthias Hebben PhD

Matthias Hebben has been serving as vice president of technology development at LogicBio Therapeutics since February 2019. In his role, he is leading the CMC efforts, including vector core, capsid optimization, process development, analytical development, and clinical product manufacturing. Before that, he served as director of technology development and head of bioprocess development at Genethon for 6 years. Before that, he occupied several positions at Vivalis (Valneva), Intervet Schering Plough, and Virbac. Matthias has a Ph.D. in molecular biology and an MSc in bioprocess engineering